Ariz. Admin. Code § R4-21-208 - Certificate of Special Qualification; Pharmaceutical Agent Number
A. The Board shall
issue a certificate of special qualification that allows a licensee to
prescribe, administer, and dispense topical diagnostic and therapeutic
pharmaceutical agents or only topical diagnostic pharmaceutical agents if the
licensee:
1. Was licensed by the Board before
July 1, 2000;
2. Held a comparable
certificate of special qualification issued by the Board before July 1, 2000;
and
3. Pays the fee prescribed at
A.R.S. §
32-1727.
B. The Board shall issue a
certificate of special qualification that indicates a licensee shall not
prescribe, administer, or dispense a pharmaceutical agent if the licensee:
1. Was licensed by the Board before July 1,
2000,
2. Did not hold a certificate
of special qualification issued by the Board before July 1, 2000, and
3. Pays the fee prescribed at A.R.S. §
32-1727.
C. A licensee who holds a
certificate of special qualification issued under subsection (A) or (B) may
apply to the Board for a pharmaceutical agent number that indicates the
licensee is authorized to prescribe, administer, or dispense topical
diagnostic, topical therapeutic, and oral pharmaceutical agents. To apply for a
pharmaceutical agent number, a licensee who holds a certificate of special
qualification issued under subsection (A) or (B) shall:
1. Submit to the Board an application, using
a form that is available from the Board, and provide the following information:
a. Name of licensee;
b. Social Security number;
c. Mailing address;
d. Telephone and fax numbers at the address
listed under subsection (C)(1)(c);
e. License number;
f. Number of certificate of special
qualification for diagnostic pharmaceutical agents, if any;
g. Number of certificate of special
qualification for therapeutic pharmaceutical agents, if any;
h. Residential address;
i. Telephone number at the address listed
under subsection (C)(1)(h);
j. Name
of the course of study approved under
R4-21-207 that the licensee completed and date of completion; and
k. Applicant's dated signature affirming that
the information provided is true and correct; and
2. Have a representative of the educational
institution at which the licensee completed the approved course of study submit
to the Board evidence that the course of study is approved and the licensee
completed all course requirements; and
3. Submit written documentation that the
licensee is currently certified in CPR.
D. The Board shall issue a pharmaceutical
agent number that indicates a licensee is authorized to prescribe, administer,
or dispense topical diagnostic, topical therapeutic, and oral pharmaceutical
agents if the licensee is initially licensed by the Board under
R4-21-201 or R4-21-202 after June 30, 2000.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.